157 related articles for article (PubMed ID: 37499419)
1. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract][Full Text] [Related]
2. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.
Sharaiha RZ; Lebwohl B; Reimers L; Bhagat G; Green PH; Neugut AI
Cancer; 2012 Aug; 118(15):3786-92. PubMed ID: 22169928
[TBL] [Abstract][Full Text] [Related]
4. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
5. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.
Sieniawski MK; Lennard AL
Curr Hematol Malig Rep; 2011 Dec; 6(4):231-40. PubMed ID: 21912848
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series.
Hong YS; Woo YS; Park G; Lee K; Kang SH; Lee HW; Kim ER; Hong SN; Chang DK; Kim YH; Rhee PL; Kim JJ
Gut Liver; 2016 Jan; 10(1):147-51. PubMed ID: 26260757
[TBL] [Abstract][Full Text] [Related]
7. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.
Tse E; Gill H; Loong F; Kim SJ; Ng SB; Tang T; Ko YH; Chng WJ; Lim ST; Kim WS; Kwong YL
Am J Hematol; 2012 Jul; 87(7):663-8. PubMed ID: 22641357
[TBL] [Abstract][Full Text] [Related]
8. Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands.
Verbeek WH; Van De Water JM; Al-Toma A; Oudejans JJ; Mulder CJ; Coupé VM
Scand J Gastroenterol; 2008; 43(11):1322-8. PubMed ID: 18618372
[TBL] [Abstract][Full Text] [Related]
9. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Delabie J; Holte H; Vose JM; Ullrich F; Jaffe ES; Savage KJ; Connors JM; Rimsza L; Harris NL; Müller-Hermelink K; Rüdiger T; Coiffier B; Gascoyne RD; Berger F; Tobinai K; Au WY; Liang R; Montserrat E; Hochberg EP; Pileri S; Federico M; Nathwani B; Armitage JO; Weisenburger DD
Blood; 2011 Jul; 118(1):148-55. PubMed ID: 21566094
[TBL] [Abstract][Full Text] [Related]
10. A case of enteropathy-associated T-cell lymphoma (type I) arising in stomach without refractory celiac disease.
Wang L; Liu Y; Lin XY; Yu JH; Miao Y; Qiu XS; Wang EH
Diagn Pathol; 2012 Dec; 7():172. PubMed ID: 23217032
[TBL] [Abstract][Full Text] [Related]
11. A case of celiac disease with type I enteropathy-associated T-cell lymphoma in a Japanese male patient.
Hiraga H; Sakuraba H; Tanaka N; Watanabe R; Akemoto Y; Ota S; Kikuchi H; Sawaya M; Hiraga N; Chinda D; Hanabata N; Mikami T; Shimoyama T; Takahata T; Tanaka M; Fukuda S
Immunol Med; 2019 Sep; 42(3):142-147. PubMed ID: 31603739
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
13. Enteropathy-associated T-cell lymphoma: improving treatment strategies.
Nijeboer P; Malamut G; Mulder CJ; Cerf-Bensussan N; Sibon D; Bouma G; Cellier C; Hermine O; Visser O
Dig Dis; 2015; 33(2):231-235. PubMed ID: 25925928
[TBL] [Abstract][Full Text] [Related]
14. [Acute intestinal obstruction revealing enteropathy associated t-cell lymphoma, about a case].
Garba AA; Adamou H; Magagi IA; Brah S; Habou O
Pan Afr Med J; 2016; 23():48. PubMed ID: 27217874
[TBL] [Abstract][Full Text] [Related]
15. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan.
Tomita S; Kikuti YY; Carreras J; Kojima M; Ando K; Takasaki H; Sakai R; Takata K; Yoshino T; Bea S; Campo E; Nakamura N
Mod Pathol; 2015 Oct; 28(10):1286-96. PubMed ID: 26226842
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
17. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
18. [Type II enteropathy-associated T-cell lymphoma: a clinicopathologic study].
Zhou J; Shen Q; Ma J; Zhang XH; Shi SS; Yu B; Zhou XJ; Shi QL
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):26-31. PubMed ID: 23611269
[TBL] [Abstract][Full Text] [Related]
19. Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis : a rare and dismal condition.
Chuah YY; Tashi T; Lee YY; Fu TY; Shih CA
Acta Gastroenterol Belg; 2020; 83(1):77-80. PubMed ID: 32233276
[TBL] [Abstract][Full Text] [Related]
20. A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma.
de Baaij LR; Berkhof J; van de Water JM; Sieniawski MK; Radersma M; Verbeek WH; Visser OJ; Oudejans JJ; Meijer CJ; Mulder CJ; Lennard AL; Cillessen SA
Clin Cancer Res; 2015 Jul; 21(13):3013-9. PubMed ID: 25779949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
